ITW

Analyzing the Lack of Analyst Enthusiasm for Illinois Tool Works (ITW)

Illinois Tool Works may be undervalued with mixed growth prospects, but the 15 analysts following the company give it an rating of hold. Their target prices range from $212.0 to $283.0 per share, for an average of $246.51. At today's price of $243.41, Illinois Tool Works is trading -1.26% away from its average target price, suggesting there is an analyst consensus of some upside potential for the stock.

Illinois Tool Works Inc. manufactures and sells industrial products and equipment in the United States and internationally. Based in Glenview, IL, the Large-Cap Industrials company has 45,000 full time employees. Illinois Tool Works has provided a 2.2% dividend yield over the last 12 months.

Illinois Tool Works has a trailing twelve month P/E ratio of 24.0, compared to an average of 25.19 for the Industrials sector. Considering its EPS guidance of $10.86, the company has a forward P/E ratio of 22.4.

Illinois Tool Works is also overpriced compared to its book value, since its P/B ratio of 24.05 is higher than the sector average of 3.17.

2018 2019 2020 2021 2022 2023
Revenue (M) $14,768 $14,109 $12,574 $14,455 $15,932 $12,088
Operating Margins 24% 24% 23% 24% 24% 33%
Net Margins 17% 18% 17% 19% 19% 24%
Net Income (M) $2,563 $2,521 $2,109 $2,694 $3,034 $2,957
Net Interest Expense (M) $257 $221 $206 $202 $203 $266
Depreciation & Amort. (M) $272 $267 $273 $277 $276 $282
Diluted Shares (M) 337 326 318 316 311 304
Earnings Per Share $7.6 $7.74 $6.63 $8.51 $9.77 $9.74
EPS Growth n/a 1.84% -14.34% 28.36% 14.81% -0.31%
Avg. Price $129.15 $138.64 $169.57 $213.16 $204.05 $243.13
P/E Ratio 16.88 17.82 25.46 24.93 20.82 24.89
Free Cash Flow (M) $2,447 $2,669 $2,571 $2,261 $1,936 $3,084
CAPEX (M) $364 $326 $236 $296 $412 $455
EV / EBITDA 13.31 13.97 19.01 19.77 17.57 19.12
Total Debt (M) $8,730 $7,762 $8,472 $8,255 $8,298 $9,525
Net Debt / EBITDA 1.87 1.58 1.87 1.79 1.87 1.96
Current Ratio 1.63 2.9 2.52 1.84 1.41 1.33
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS